Cargando…

The effect of infliximab on rheumatoid factor and anti-citrullinated cyclic peptide antibodies

Detalles Bibliográficos
Autores principales: van Damme, N, de Rycke, L, Kruithof, E, Hoffman, IEA, Veys, EM, de Keyser, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273063/
http://dx.doi.org/10.1186/ar517
_version_ 1782222863040774144
author van Damme, N
de Rycke, L
Kruithof, E
Hoffman, IEA
Veys, EM
de Keyser, F
author_facet van Damme, N
de Rycke, L
Kruithof, E
Hoffman, IEA
Veys, EM
de Keyser, F
author_sort van Damme, N
collection PubMed
description
format Online
Article
Text
id pubmed-3273063
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32730632012-02-07 The effect of infliximab on rheumatoid factor and anti-citrullinated cyclic peptide antibodies van Damme, N de Rycke, L Kruithof, E Hoffman, IEA Veys, EM de Keyser, F Arthritis Res Meeting Abstract BioMed Central 2002 2002-02-04 /pmc/articles/PMC3273063/ http://dx.doi.org/10.1186/ar517 Text en
spellingShingle Meeting Abstract
van Damme, N
de Rycke, L
Kruithof, E
Hoffman, IEA
Veys, EM
de Keyser, F
The effect of infliximab on rheumatoid factor and anti-citrullinated cyclic peptide antibodies
title The effect of infliximab on rheumatoid factor and anti-citrullinated cyclic peptide antibodies
title_full The effect of infliximab on rheumatoid factor and anti-citrullinated cyclic peptide antibodies
title_fullStr The effect of infliximab on rheumatoid factor and anti-citrullinated cyclic peptide antibodies
title_full_unstemmed The effect of infliximab on rheumatoid factor and anti-citrullinated cyclic peptide antibodies
title_short The effect of infliximab on rheumatoid factor and anti-citrullinated cyclic peptide antibodies
title_sort effect of infliximab on rheumatoid factor and anti-citrullinated cyclic peptide antibodies
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273063/
http://dx.doi.org/10.1186/ar517
work_keys_str_mv AT vandammen theeffectofinfliximabonrheumatoidfactorandanticitrullinatedcyclicpeptideantibodies
AT deryckel theeffectofinfliximabonrheumatoidfactorandanticitrullinatedcyclicpeptideantibodies
AT kruithofe theeffectofinfliximabonrheumatoidfactorandanticitrullinatedcyclicpeptideantibodies
AT hoffmaniea theeffectofinfliximabonrheumatoidfactorandanticitrullinatedcyclicpeptideantibodies
AT veysem theeffectofinfliximabonrheumatoidfactorandanticitrullinatedcyclicpeptideantibodies
AT dekeyserf theeffectofinfliximabonrheumatoidfactorandanticitrullinatedcyclicpeptideantibodies
AT vandammen effectofinfliximabonrheumatoidfactorandanticitrullinatedcyclicpeptideantibodies
AT deryckel effectofinfliximabonrheumatoidfactorandanticitrullinatedcyclicpeptideantibodies
AT kruithofe effectofinfliximabonrheumatoidfactorandanticitrullinatedcyclicpeptideantibodies
AT hoffmaniea effectofinfliximabonrheumatoidfactorandanticitrullinatedcyclicpeptideantibodies
AT veysem effectofinfliximabonrheumatoidfactorandanticitrullinatedcyclicpeptideantibodies
AT dekeyserf effectofinfliximabonrheumatoidfactorandanticitrullinatedcyclicpeptideantibodies